title: [Dynamics of prevalence of arterial hypertension and other risk factors of development of cardiovascular diseases in female population of Tallin (10 year prospective study)].
abstract: Aim of the study was to assess dynamics of prevalence of arterial hypertension (AH) and main cardiovascular risk factors (RF) in a women population of Tallin during 10 years of follow up. In 2008-2009 we repeated measurements of arterial pressure (AP), electrocardiographic, echocardiographic, and complex laboratory examinations in 314 participants of epidemiological study undertaken in 1999-2000. Most prevalent RF was hypercholesterolemia. Rate of its detection substantially rose from 69.1 to 81.2%. Number of subjects who continuously took cholesterol lowering drugs and had target levels of lipid profile was sporadic. Prevalence of hypertriglyceridemia, obesity, and diabetes mellitus insignificantly increased. Only prevalence of smoking had tendency to reduction. AH was found in 28.7 and 44.6% of women in 1999-2000 and 2009, respectively. Obesity and hypercholesterolemia contributed significantly to development of new cases of AH. Among subjects with AH 25% of women received antihypertensive therapy and achieved target AP levels--3 times more than in 2000. Thus prevalence of AH and other main RF in female population of Tallin increased during 10 years follow-up. However control of AP in patients with AH notably improved.
authors.forename: T
authors.initials: T
authors.lastname: Shipilova
authors.forename: I
authors.initials: I
authors.lastname: Pshenichnikov
authors.forename: E
authors.initials: E
authors.lastname: Abina
authors.forename: D
authors.initials: D
authors.lastname: Karaĭ
authors.forename: E
authors.initials: E
authors.lastname: Ripul'k
authors.forename: K
authors.initials: K
authors.lastname: Veski
authors.forename: K
authors.initials: K
authors.lastname: Pil't
authors.forename: K
authors.initials: K
authors.lastname: Meĭgas
authors.forename: Iu
authors.initials: Iu
authors.lastname: Kaĭk
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D004957:Estonia / Q000453:epidemiology; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology* / Q000378:metabolism / Q000503:physiopathology; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000639:trends*; D009765:Obesity / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D015995:Prevalence; D011787:Quality of Health Care / Q000639:trends*; D012189:Retrospective Studies; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents